newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

Zurich, Switzerland, Sept. 04, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA" or the "Company")), a leading developer of next-generation antibody-based cancer therapies, today